These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6148245)

  • 1. Cardiac slowing induced by peripheral kappa-opiate receptor stimulation in rats.
    Gautret B; Schmitt H
    Eur J Pharmacol; 1984 Jun; 102(1):159-63. PubMed ID: 6148245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagally mediated reflex and cardiac slowing induced by loperamide in rats.
    Gautret B; Schmitt H
    Eur J Pharmacol; 1985 Jan; 107(2):157-60. PubMed ID: 2984000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral sites for cardiovascular actions of dynorphin-(1-13) in rats.
    Gautret B; Schmitt H
    Eur J Pharmacol; 1985 May; 111(2):263-6. PubMed ID: 2410282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
    Gué M; Junien JL; Bueno L
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1006-10. PubMed ID: 2550612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa opioid agonists and antagonists: effects on drinking and urinary output.
    Leander JD
    Appetite; 1984 Mar; 5(1):7-14. PubMed ID: 6091543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethylketocyclazocine decreases noradrenaline release and blood pressure in the rabbit at a peripheral opioid receptor.
    Ensinger H; Hedler L; Schurr C; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):20-3. PubMed ID: 6096725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
    Huidobro-Toro JP; Parada S
    Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sites for the cardiovascular actions of fentanyl in rats.
    Gautret B; Schmitt H
    J Cardiovasc Pharmacol; 1985; 7(4):649-52. PubMed ID: 2410703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a kappa receptor agonist, ethylketocyclazocine, on water consumption in water-deprived and nondeprived rats in diurnal and nocturnal tests.
    Turkish S; Cooper SJ
    Pharmacol Biochem Behav; 1984 Jul; 21(1):47-51. PubMed ID: 6087378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.
    Shearman GT; Herz A
    Psychopharmacology (Berl); 1982; 78(1):63-6. PubMed ID: 6292982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kappa opioid receptor and food intake.
    Morley JE; Levine AS; Kneip J; Grace M; Zeugner H; Shearman GT
    Eur J Pharmacol; 1985 May; 112(1):17-25. PubMed ID: 2990965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evidence for benzomorphan-selective receptors in rats.
    Gmerek DE; Cowan A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):110-5. PubMed ID: 6146703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 17. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors.
    Shearman GT; Herz A
    J Pharmacol Exp Ther; 1982 Jun; 221(3):735-9. PubMed ID: 6283060
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-ratio comparison of mu and kappa agonists in formalin and thermal pain.
    Abbott FV; Franklin KB; Libman RB
    Life Sci; 1986 Nov; 39(21):2017-24. PubMed ID: 3023775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.